1Swaak, AJ, van den Brink, HG, Smeenk, RJ, et al. (1999) Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation. Rheumatology (Oxford, England) 38, 953–958.
2Agrawal, N, Chiang, LK & Rifkin, IR (2006) Lupus nephritis. Semin Nephrol 26, 95–104.
3Mason, LJ & Berden, JH (2008) Pathogenic factors for the development of lupus nephritis. Lupus 17, 251–255.
4Mortensen, ES, Fenton, KA & Rekvig, OP (2008) Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 172, 275–283.
5Bagavant, H & Fu, SM (2009) Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 21, 489–494.
6Chan, OT, Madaio, MP & Shlomchik, MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169, 107–121.
7Wofsy, D & Seaman, WE (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161, 378–391.
8Houssiau, FA (2004) Management of lupus nephritis: an update. J Am Soc Nephrol 15, 2694–2704.
9Raimondi, G, Turner, MS, Thomson, AW, et al. (2007) Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 27, 61–95.
10Sakaguchi, S, Ono, M, Setoguchi, R, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212, 8–27.
11Nishimura, E, Sakihama, T, Setoguchi, R, et al. (2004) Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+ CD25+ CD4+ regulatory T cells. Int Immunol 16, 1189–1201.
12Minami, R, Sakai, K, Miyamura, T, et al. (2006) [The role of CD4+ CD25+ regulatory T cells in patients with rheumatoid arthritis]. Nihon Rinsho Meneki Gakkai Kaishi 29, 37–42.
13Viglietta, V, Baecher-Allan, C, Weiner, HL, et al. (2004) Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199, 971–979.
14Alvarado-Sanchez, B, Hernandez-Castro, B, Portales-Perez, D, et al. (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27, 110–118.
15Ammon, HP & Wahl, MA (1991) Pharmacology of Curcuma longa. Planta Med 57, 1–7.
16Natarajan, C & Bright, JJ (2002) Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168, 6506–6513.
17Sugimoto, K, Hanai, H, Tozawa, K, et al. (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123, 1912–1922.
18Khajehdehi, P, Zanjaninejad, B, Aflaki, E, et al. (2012) Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr 22, 50–57.
19Foster, MH (1999) Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin Nephrol 19, 12–24.
20Limtrakul, P, Lipigorngoson, S, Namwong, O, et al. (1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116, 197–203.
21Hori, S, Nomura, T & Sakaguchi, S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061.
22Szabo, SJ, Kim, ST, Costa, GL, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669.
23Yamashita, M, Ukai-Tadenuma, M, Miyamoto, T, et al. (2004) Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 279, 26983–26990.
24Ando, DG, Sercarz, EE & Hahn, BH (1987) Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol 138, 3185–3190.
25Stevens, TL, Bossie, A, Sanders, VM, et al. (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255–258.
26Fontenot, JD, Gavin, MA & Rudensky, AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nature Immunol 4, 330–336.
27Sakaguchi, S, Sakaguchi, N, Asano, M, et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151–1164.
28Wolf, D, Hochegger, K, Wolf, AM, et al. (2005) CD4+ CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16, 1360–1370.
29Hayashi, T, Hasegawa, K & Adachi, C (2005) Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB × NZW F mice. Int J Exp Pathol 86, 289–296.